Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience

BACKGROUND: Determinates of tumor treating fields (TTFields) usage in patients receiving combined modality therapy for primary IDH wild-type glioblastoma are currently unknown. METHODS: Ninety-one patients underwent maximal debulking surgical resection, completed external beam radiotherapy with conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballo, Matthew T, Qualls, Kaitlin W, Michael, L Madison, Sorenson, Jeffrey M, Baughman, Brandon, Karri-Wellikoff, Saradasri, Pandey, Manjari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555297/
https://www.ncbi.nlm.nih.gov/pubmed/36249289
http://dx.doi.org/10.1093/noajnl/vdac150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555297/
https://www.ncbi.nlm.nih.gov/pubmed/36249289
http://dx.doi.org/10.1093/noajnl/vdac150

Ejemplares similares